フォトアルバム

サイト内検索

  • Google Custom Search

2013年11 月

          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

おすすめブログ

最近のトラックバック

« 7大陸最高峰登頂に成功した産婦人科1人部長o(^-^)o..。*♡ | メイン | 「病院勤務医の開業医志向」は存在せず? »

コメント

鶴亀松五郎

CDCが7月29日に新型flu A(H1N1)ワクチン接収の優先順位を発表しています。

妊婦さん、第一に挙げられていますね。

The committee recommended the vaccination efforts focus on five key populations.

・pregnant women,

・people who live with or care for children younger than 6 months of age,

・health care and emergency services personnel,

・persons between the ages of 6 months through 24 years of age,

・people from ages 25 through 64 years who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.

とくにワクチンの不足も予測されるので、

・pregnant women,

・people who live with or care for children younger than 6 months of age,

・health care and emergency services personnel with direct patient contact,

・children 6 months through 4 years of age, and

・children 5 through 18 years of age who have chronic medical conditions.

は、他のグループよりも先にワクチン接種すべきと。

先に、ハイリスク・グループのワクチン接種を満たしたあとで、比較的リスクの少ないグループ、すなわち特に65歳以上のグループに接種していくように。

65歳以上のグループはむしろ、季節性fluワクチンが供給できしだい、すぐに接種すべきでる。

新型flu A(H1N1)ワクチンは季節性fluワクチンに置き換わるものではないので、季節性fluワクチンは並行して接種することも考慮すべき。

二つのワクチンを同じ日に提供すること(接種する?)も可能である。

本文はこちら↓

◎CDC Advisors Make Recommendations for Use of Vaccine Against Novel H1N1
http://www.cdc.gov/media/pressrel/2009/r090729b.htm

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) met today to make recommendations for use of vaccine against novel influenza A (H1N1).

The committee met to develop recommendations on who should receive vaccine against novel influenza A (H1N1) when it becomes available, and to determine which groups of the population should be prioritized if the vaccine is initially available in extremely limited quantities.

The committee recommended the vaccination efforts focus on five key populations. Vaccination efforts are designed to help reduce the impact and spread of novel H1N1. The key populations include those who are at higher risk of disease or complications, those who are likely to come in contact with novel H1N1, and those who could infect young infants. When vaccine is first available, the committee recommended that programs and providers try to vaccinate:

・pregnant women,

・people who live with or care for children younger than 6 months of age,

・health care and emergency services personnel,

・persons between the ages of 6 months through 24 years of age,

・and people from ages 25 through 64 years who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.

The groups listed above total approximately 159 million people in the United States.

The committee does not expect that there will be a shortage of novel H1N1 vaccine, but availability and demand can be unpredictable. There is some possibility that initially the vaccine will be available in limited quantities. In this setting, the committee recommended that the following groups receive the vaccine before others:

・pregnant women,

・people who live with or care for children younger than 6 months of age,

・health care and emergency services personnel with direct patient contact,

・children 6 months through 4 years of age, and

・children 5 through 18 years of age who have chronic medical conditions.

The committee recognized the need to assess supply and demand issues at the local level. The committee further recommended that once the demand for vaccine for these prioritized groups has been met at the local level, programs and providers should begin vaccinating everyone from ages 25 through 64 years. Current studies indicate the risk for infection among persons age 65 or older is less than the risk for younger age groups. Therefore, as vaccine supply and demand for vaccine among younger age groups is being met, programs and providers should offer vaccination to people over the age of 65.

The committee also stressed that people over the age of 65 receive the seasonal vaccine as soon as it is available. Even if novel H1N1 vaccine is initially only available in limited quantities, supply and availability will continue, so the committee stressed that programs and providers continue to vaccinate unimmunized patients and not keep vaccine in reserve for later administration of the second dose.

The novel H1N1 vaccine is not intended to replace the seasonal flu vaccine. It is intended to be used alongside seasonal flu vaccine to protect people. Seasonal flu and novel H1N1 vaccines may be administered on the same day.

鶴亀松五郎

英国ガーディアン紙もランセットに掲載されたCDCの論文のカバー記事を出しています。妊婦はまず最初に新型flu A(H1N1)ワクチンを接種すべきという内容です。

また、胎児に関する抗ウィルス薬のリスクは不明だが、リスクよりもベネフィットの方が大きいとランセットの論文を書いた科学者は述べています。

CDCの分析でも、新型flu感染の妊婦の入院は、一般人の4倍になる。
また、死亡率も高い(妊婦は米国人口の1%だが、現在までの新型fluによる死者の6%を占める)。

4月から6月までの米国における新型fluの死者のうち、妊婦は16%にものぼる。

1918年と1957年のインフルエンザ・パンデミックの時の妊婦の死亡率も、妊婦でない人々より高かった。

1957年の時のアジアfluのとき、ミネソタ州において、妊娠可能な年代の女性のうちの死者の50%は妊婦だった。

48時間以内に即座に新型fluに対して、抗ウィルス薬を処方された妊婦のなかで、死者は出なかった。

新型fluのワクチンが出たら、妊婦は優先的にワクチン接種をすべきであるが、胎児への影響を恐れてワクチン接種を控える妊婦がいる。

本文はこちら↓

◎Give pregnant women priority for swine flu vaccine
study urgesArticle in Lancet says risk of complications is higher, with worrying death rate from virus among expectant mothers
ガーディアン Wednesday 29 July 2009
http://www.guardian.co.uk/world/2009/jul/29/swine-flu-pregnant-woman-lancet

Pregnant women should be prioritised for the flu vaccine as soon as it is available, according to the authors of a study showing they are more at risk of complications and more likely to end up in hospital than other people.

Women expecting a baby should also be given antiviral drugs as soon as they get the flu, says the paper published online today by the Lancet medical journal. Little is known about the possible ill-effects of the drugs on the foetus but scientists say their benefits are likely to be greater than the risks.

The research comes from the US, where six pregnant women died of swine flu complications between 15 April and 18 May. In that month, 34 confirmed or probable cases of swine flu were reported to the Centres for Disease Control and Prevention (CDC) from 13 states. Eleven of them were admitted to hospital.

The rate of admission to hospital is four times higher than in the general population, say the authors, Dr Denise Jamieson from the CDC's division of reproductive health in Atlanta and colleagues. That could be because doctors are more nervous about the effects if flu on pregnant women and are more likely to admit them, but the death rate among pregnant women is high.

"Although the decision to admit a pregnant woman is complex and might include considerations beyond simply the severity of disease, that a high proportion (greater than 10%) of influenza-related deaths in the USA have been in pregnant women is concerning," they write.

"In the previous influenza pandemics of 1918 and 1957, mortality seemed to be higher in pregnant women than in non-pregnant populations ... During the pandemic of 1957, 50% of deaths due to Asian influenza in Minnesota among women of reproductive age occurred in pregnant women."

None of the women who died had been given antiviral drugs promptly, within the first 48 hours of symptoms occurring, they write.

Once a vaccine is available, pregnant women will be a high priority, the authors say. However they are concerned that women may not come forward to be vaccinated because of fear of any effect on their baby. Few pregnant women choose to be immunised against winter flu.

風はば

貴重なインフルエンザ情報有難う御座います。

日々の仕事が大変そうですが、体を壊さない程度に、ご自愛なさって下さい。

僻地の産科医

うわぁ~い(>▽<)!!!
ありがとうございます。

もう、アレなコレで、かなりアレげな感じです。(わからないですね(笑)。)ま、そもそも全体的に腐臭が漂っているというか。

>返事はない。ただの屍のようだ。

(あ、ちなみにドラクエはやっていません)
ほにゃらら~。

この記事へのコメントは終了しました。